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Abstract
Background: Retention in HIV care is critical to maintaining viral suppression and preventing further transmission, yet less
than 50% of people living with HIV in the United States are engaged in care. All US states have a funding mandate to implement
Data-to-Care (D2C) programs, which use surveillance data (eg, laboratory, Medicaid billing) to identify out-of-care HIV-positive
persons and relink them to treatment.
Objective: The purpose of this qualitative study was to identify and describe practical and ethical considerations that arise in
planning for and implementing D2C.
Methods: Via purposive sampling, we recruited 43 expert stakeholders—including ethicists, privacy experts, researchers, public
health personnel, HIV medical providers, legal experts, and community advocates—to participate in audio-recorded semistructured
interviews to share their perspectives on D2C. Interview transcripts were analyzed across a priori and inductively derived thematic
categories.
Results: Stakeholders reported practical and ethical concerns in seven key domains: permission and consent, government
assistance versus overreach, privacy and confidentiality, stigma, HIV exceptionalism, criminalization, and data integrity and
sharing.
Conclusions: Participants expressed a great deal of support for D2C, yet also stressed the role of public trust and transparency
in addressing the practical and ethical concerns they identified.
(JMIR Public Health Surveill 2020;6(3):e19891) doi: 10.2196/19891
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Retention in HIV care is critical to maintaining viral suppression
and preventing further transmission, yet less than 50% of people
living with HIV in the United States are engaged in care, and
only 56% are virally suppressed [1]. Common barriers to
remaining in care include: feeling depressed or stigmatized;
substance use; low literacy; day-to-day responsibilities,
including work or school; inadequate housing, insurance, and
related financial problems; lack of reliable transportation,
particularly for rural populations; and institutional variability
in attempts to contact and locate patients who miss appointments
[2-6]. Low care engagement results in excess morbidity and
mortality among people living with HIV and fuels HIV
transmission [7]. Accordingly, identifying out-of-care people
living with HIV and linking them to sustainable care is essential
to addressing the HIV epidemic.
As interconnecting sources of electronic data expand, state and
local health departments are increasingly pursuing novel
strategies, including health information technologies, to
re-engage out-of-care people living with HIV in care [8,9]. All
states in the US have a funding mandate to implement
Data-to-Care (D2C) programs, which use surveillance data such
as HIV viral load test results, Medicaid claims records, or
electronic health records from private or state-run systems to
identify out-of-care HIV-positive persons and re-link them to
treatment. Because HIV viral load test results are mandatorily
reported to public departments of health (DOH), they can be
used to assess retention in care.
In the DOH model of D2C, which we focus on here, the first
step is for a state or local DOH to use its surveillance data to
generate a list of people living with HIV identified as being out
of care. Typically, this is defined as someone who has not had
a viral load laboratory test reported in the previous 12 months.
Because misclassification of care status can occur while using
reported viral load test results due to delays and incomplete
reporting [10], additional data sources, such as state Medicaid
records, electronic health records, or mortality records, may be
checked to verify whether a person is not in care. Public health
personnel can then contact the patient’s last known HIV
provider. If the patient is confirmed to be out of care, the health
care provider may try to contact the patient, or a specially trained
public health outreach worker employed by the DOH may reach
out to the patient, either by telephone or in-person. The outreach
worker or health care provider will then assess whether the
patient is indeed out of care, and if so, why. The goal of this
contact is to help patients overcome any barriers so that they
can resume care [11].
Preliminary research suggests that D2C activities are effective
at re-engaging out-of-care individuals in care [12-14], yet few
studies have examined the practical and ethical issues raised by
such novel applications of health information technologies
[15-17]. For example, physicians have expressed concerns about
DOH personnel intruding on patient privacy and the
physician-patient relationship [18]. The purpose of this study
was to identify and describe practical and ethical considerations
that arise in planning for and implementing D2C.
Methods
Overview
This article reports findings from a larger qualitative study of
expert stakeholders’perspectives on the potential to use criminal
justice system data to enhance surveillance and D2C to
understand and improve continuity of care among people living
with HIV/AIDS in North Carolina who have spent time in
county jails. For this sub-study, we focus on stakeholders’
reported views on the current use of D2C in the general
population. The Institutional Review Board of the University
of North Carolina at Chapel Hill approved the study. Below we
describe our methods for recruitment, data collection, and
analysis. A full description of the parent study, data collection,
and analysis are provided elsewhere [19].
Data Collection
Expert stakeholders were recruited via a purposive sampling
strategy in which we aimed to recruit three to five participants
in several categories of professional expertise (public health,
ethics and privacy, legal experts and criminal justice personnel,
and community advocates). Potential participants were identified
using a combination of methods, including the research team’s
professional network, literature review and online searches, and
snowball sampling. Because the larger study was focused on
applications of enhanced surveillance methods and D2C to
North Carolina jails, we oversampled expert stakeholders located
in North Carolina. Prospective participants were invited over
email to participate in the study.
Semistructured interview guides included questions about the
participant’s professional background and perspectives on HIV
surveillance and D2C in the general population, the potential
use of HIV surveillance and D2C in North Carolina jails,
privacy, community engagement, data governance, and research
practices. In some cases, guides were further tailored to
stakeholder categories to collect specific information. For
example, DOH personnel were asked additional questions about
D2C operations. This article focuses on participants’ responses
to questions about HIV surveillance and D2C in the general
population. Three members of the research team with training
in qualitative interviewing conducted all interviews after
obtaining informed consent. Except for one participant,
interviews were audio-recorded and conducted either in person
(n=28) or via videoconference (n=12) or telephone (n=3).
Interviews were conducted between April 2018 and August
2019 and lasted between 40 and 107 minutes.
Data Analysis
We used Dedoose software to analyze interview transcripts
across twenty-two thematic codes. After coding was completed
using a set of procedures reported elsewhere [19], we identified
salient themes for further analysis and further examined coding
reports from each coding category to identify patterns across
the larger dataset. For this article, we focused on stakeholders’
responses in seven thematic domains relevant to practical and
ethical concerns in implementing D2C: permission and consent,
government assistance vs overreach, privacy and confidentiality,
HIV stigma, HIV exceptionalism, HIV criminalization, and data
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integrity and sharing. For this substudy, we excluded responses
from four jail administrators, whose expertise was not relevant
to this analysis.
Results
Forty-three expert stakeholders—including ethicists, privacy
experts, researchers, public health personnel, HIV medical
providers, legal experts, and community advocates—participated
in this sub-study (see Table 1). The majority of participants
came from North Carolina (26/43); the remainder lived in other
states (n=15) or outside the United States (n=2). Participants
universally acknowledged the public health needs that
DOH-based D2C programs aim to address, and most expressed
support for the public health goals such programs fulfill. As
one participant put it, “I feel if you have a public health
imperative and you can do things about that, and you can treat
and basically save people’s lives, that you have a responsibility
to try to do that.” In discussing the practical and ethical
considerations of implementing such programs, however,
participants qualified their support with a range of significant
concerns, which clustered into the seven themes identified
above. Below, we describe findings from each theme in more
detail. We offer illustrative quotations from stakeholders in
Table 2.
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• Permission should be obtained: “Absolutely they should have permission…People might not even know that they’re in a
surveillance system. And given the potentially adverse consequences of the use of that data, there might be cause for concern
there for those folks.” (1010, privacy expert)
• Obtaining permission would impede public health objectives: “Probably hard to have a program like this that’s opt in. When
you do that, either no one does or the only people who do are people getting treatment already.” (1035, privacy expert)
Government assis-
tance vs overreach
• D2Cais justified assistance: “So, for HIV we intercede, we stick our noses into people's medical records extensively with
the practical goal of making sure people receive treatment, which is not ethically a bad goal, but it can be highly intrusive,
although we try to do it sensitively, and is not everybody's personal goal.” (1002, public health employee)
• D2C is government overreach: “There are a lot of things that people do or don’t do that affect health or wellbeing or
whatever and the state could intervene with them to say do better…Kind of a nanny state.” (1035, privacy expert)
Privacy and confi-
dentiality
• Health worker showing up could breach confidentiality: “[A] state health official showing up could alert family members,
could alert folks in the neighborhood, could alert others in the household. Hey, there’s something. We’re not sure what,
but there’s something going on.” (1011, researcher)
• People may not want to be contacted: “[There’s] reasons people are not in this care continuum. And they may not want to
be found. They may think finding them will bring other kinds of surveillance that they’re not interested in having.” (1013,
ethicist)
HIV stigma • D2C could exacerbate stigma: “The way that [the D2C] system works, I don’t see that as helpful, because you’ve got these
strange people knocking on your door looking for you, and you don’t really understand who these strange people are. And
because these people are appropriately afraid of the system they always think somebody’s coming after them to incarcerate
them, to take them to court. So that deepens the stigma.” (1036, HIV Provider)
HIV exceptional-
ism
• Not problematic that D2C is focused on HIV: “HIV is exceptional because HIV is different. And it’s exceptional in lots of
ways. So, our response to it has to be exceptional in some ways.” (1030, ethicist)
• D2C focus on HIV is stigmatizing: “It almost seems stigmatizing in the way that [HIV] is so singled out and so hyper focused
on. Not that it doesn’t deserve that amount of focus and resources, but that it’s to the exclusion of other things…A job, etc.”
(1033, criminal justice advocate)
HIV criminaliza-
tion
• D2C could lead to punitive measures for PLWH: “The community doesn’t see it that way. They see [D2C] as a way that
will create opportunities for criminalization, that it can be used against people. (1021, HIV advocate)
Data integrity and
sharing
• D2C increases risk of data reaching “the wrong hands”: “I would say that there are probably potentially more risks because,
as more data changes hands, there’s always the possibility that it could end up in the wrong place or in the wrong hands.”
(1031, public health personnel)
• Data could be misused: “I think that the fears that the individuals have that the data will be used in some other way that
the—I don’t want to say criminal, but certainly the people in government might start misusing those data in ways that were
not intended from big data work for that. And then the current environment, governmental environment in the country I
think that that fear is incredibly reasonable.” (1047, HIV advocate)
aD2C: data-to-care.
Permission and Consent
Stakeholders were largely divided by stakeholder type on
whether permission and consent for D2C should be obtained.
Those in favor of obtaining consent for future contact associated
with D2C at the time of diagnosis—including most privacy and
legal experts, community advocates, and some ethicists—argued
that doing so would demonstrate respect and dignity, improve
the government’s credibility, and that the risks of public harm
created by potential refusals were too low to justify overriding
consent on public health grounds. However, even those who
thought consent should be obtained acknowledged the practical
challenges of doing so, and that permitting people to opt out
would potentially impede the efficacy of D2C.
Others—including most public health personnel, researchers,
and some ethicists—argued that forgoing consent was justified
because D2C is a core component of public health surveillance,
which does not require consent. They argued that obtaining
consent would limit the state DOH’s ability to intervene and
that the state should act on this information to return out-of-care
patients to care rather than do nothing. One public health
employee noted that if surveillance is to proceed without
informed consent, treatment must be non-coercive. Several
others suggested that in lieu of consent, the DOH should inform
people that D2C is occurring, ideally through providers’offices.
One researcher suggested this is best framed as a way to support
people living with HIV, rather than a response to “falling out
of care.”
Government Assistance Versus Overreach
Five public health personnel emphasized that the state DOH
has a responsibility to the public to implement D2C, even at the
expense of some individual privacy. They argued that the
agency’s public health mission and legal authority provide
adequate justification for the level of state intrusion required
for D2C, as long as the right to refuse care is ultimately
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preserved. On the other hand, 11 stakeholders, particularly
ethicists, researchers, privacy experts, and some public health
personnel, thought that people would object to the state tracking
them or contacting them about their healthcare through
surveillance and D2C, and some thought that this might
constitute an unwelcome form of government intrusion. Six of
them explicitly suggested that such activities reflected the work
of “Big Brother” or a “nanny state.” Overall, participants
expressed concerns about the potential for government overreach
more frequently than they defended the necessity of this type
of assistance. Nevertheless, ten stakeholders still thought the
benefits of D2C outweighed the risks of government overreach,
and several had suggestions for how to mitigate these concerns
through implementation procedures.
Privacy and Confidentiality
Stakeholders uniformly acknowledged that a health worker
showing up at someone’s home as a result of D2C activities
could constitute an unwanted invasion of privacy by alerting
family members or neighbors to a potential problem. Four noted
that these types of privacy concerns might be more pronounced
in areas with heightened HIV stigma (see below), particularly
in rural areas, and that these violations could have serious
ramifications for trust in government. Eight stakeholders saw
such intrusions into private space as a more significant violation
because people living with HIV may not want to be contacted
for linkage to care and have a legal and ethical right to refuse
care. One public health employee suggested that this type of
privacy violation is especially significant in the D2C context
because informed consent is not obtained, and HIV surveillance
data is being used differently from its initial authorized purpose,
which was purely for tracking rather than recontacts and linkage
to care.
The potential for inadvertent disclosure was the biggest concern
associated with D2C. Stakeholders displayed different levels
of trust that private health information collected as a result of
D2C will remain confidential. DOH personnel noted that
community health workers are very well-trained, suggesting a
low probability for disclosure, while privacy experts averred
that the risk of a breach increases with more people accessing
confidential information, regardless of the context. Several HIV
providers reported that their patients had had negative
experiences with disease intervention specialists (DOH
employees who contact people newly diagnosed with HIV to
collect information about potential contacts and risk factors and
to help connect them to care) at the time of diagnosis. These
experiences suggested to these HIV providers the potential for
a breach of confidentiality by DOH outreach workers engaged
in D2C. One researcher viewed sharing confidential information
with health workers as a breach in itself. Four stakeholders
suggested that the risk of a breach may be greater in rural
communities where there may be a greater risk of overlap in
the social networks of health workers and the communities they
serve.
HIV Stigma
Many stakeholders suggested that the public response to D2C
depended in part on HIV stigma. While some stakeholders
believed that HIV stigma has decreased over time,
others—particularly HIV providers—still see evidence of
substantial stigma (eg, patients traveling far away from their
home communities to access HIV care or choosing to forego
care). Fourteen participants mentioned that D2C could
potentially heighten HIV stigma through unwanted attention
from state health workers, privacy violations, and inadvertent
disclosure, yet varied in terms of how likely they viewed this
scenario. Concerns about this possibility were embedded in
broader concerns related to the marginalization of vulnerable
groups (eg, African Americans, men who have sex with men,
and transgender people) and HIV exceptionalism (discussed
further below). Three stakeholders cautioned that D2C could
be implemented in a way that alienates people from systems of
care, produces panic, or overlooks the circumstances of people’s
lives in ways that reinforce stigma.
HIV Exceptionalism
HIV exceptionalism is the view that, for a variety of reasons,
HIV is or should be treated differently than other communicable
diseases or conditions that may result in death if untreated. D2C
may be an example of HIV exceptionalism because it is used
widely for HIV, but much less commonly for other conditions.
Stakeholders were overall split regarding whether it is
problematic for D2C to focus on HIV, with many people
remaining uncertain. Six participants raised the possibility that
HIV exceptionalism heightens stigma, and four suggested that
if there were similar surveillance-based interventions for other
conditions, it might reduce some of the stigmas around HIV
because people would not feel singled out for their HIV status.
Ten participants indicated that D2C should be used for other
conditions, especially infectious or sexually transmitted diseases.
HIV Criminalization
When asked about possible risks or harms of HIV surveillance
and D2C, 12 stakeholders mentioned the possibility that D2C
could lead to punitive measures for people living with HIV.
Some state laws require people living with HIV to disclose their
HIV status to partners if they are not virally suppressed. One
ethicist stated that HIV surveillance is necessarily problematic
in a context in which HIV is criminalized. At the same time, a
community HIV advocate noted that the potential for
criminalization could be used to try to persuade people living
with HIV who have fallen out of care to re-establish care.
Data Integrity and Sharing
Data integrity is a basic tenet of public health surveillance
because there are always increased security risks when using
and sharing data. Many participants expressed concerns that
D2C programs could inadvertently result in sensitive personal
information reaching the “wrong hands,” particularly in rural
areas. Possible risks of someone outside of DOH personnel
illegally obtaining data include data breaches and malware
attacks. Four stakeholders, including a privacy expert,
community advocate, and two legal experts, raised concerns
about the possible harms that might occur if D2C personnel
obtained erroneous data. For example, incorrect data could lead
state health workers to contact the wrong person for
re-engagement in care. Nevertheless, public health personnel
reported that wrongful identification, although possible, was
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rare due to rigorous data cleaning and matching before field
contacts are attempted.
Four stakeholders mentioned concerns about possible misuse
of the data by the government—for example, suggesting that
the information might be shared with legislators to enhance
criminalization laws. Several stakeholders noted that many
people do not understand or trust data protections and that the
government sponsorship of D2C increases mistrust, especially
among African American communities. Stakeholder
recommendations included: creating oversight for how data is
collected, used, and shared, including necessary safeguards to
protect against breach or misuse, checks and balances to ensure
the data is accurate, and strong security measures.
Discussion
Expert stakeholders expressed a range of ethical and practical
concerns related to the use of D2C to improve the continuity of
HIV care. Most stakeholders acknowledged that using big data
methods to re-engage patients in care is a logical extension of
public health surveillance that is justified by the mission of state
and local health departments to reduce HIV transmission and
promote public health. At the same time, D2C also represents
a new application of existing surveillance data that may raise
the suspicions of some community members [20,21]. The
tension between government assistance and government
overreach encapsulates the promise and pitfalls of using D2C
and other big data technologies in public health interventions.
Responses from expert stakeholders emphasized that context
matters greatly to the ethics of D2C. Many stakeholders
suggested that privacy and stigma concerns are more pronounced
in areas of the rural south where many study participants are
located and among vulnerable groups such as racial, ethnic, and
gender and sexual minorities. Our findings lend additional
support to previous studies suggesting that stakeholder
engagement in program implementation is critical for ensuring
that D2C programs and other public health surveillance
programs are designed in contextually sensitive ways [22,23],
particularly given the high degree of support for the notion that
D2C could heighten stigma. The public response to digital
surveillance has demonstrated this point during the COVID-19
pandemic, which may reinforce the distrust of public health
authorities [24].
At the same time, a few stakeholders expressed caution about
community engagement. Two participants noted that some
people might feel exploited if the motivations for engagement
are not genuine, and one suggested that community engagement
may inadvertently lead to the spread of misinformation. These
findings suggest that care must likewise be taken concerning
data protection and data stewardship, both to safeguard against
potential breaches and to ensure the trust of the community.
Such efforts can mitigate potential mistrust of government
motives regarding D2C and the necessary privacy violations
entailed. While conducting HIV surveillance without individual
informed consent has been ethically justified [15,16,25], the
strength of concerns expressed by several stakeholder groups
(eg, community advocates, privacy and legal experts) about the
lack of informed consent highlight the importance of making
communities aware of these public health activities and the
reasons for forgoing consent. Such public transparency is a
critical component of stakeholder engagement as D2C continues
to evolve.
The strengths of this study include its qualitative design, which
is well equipped for capturing rich descriptive information
regarding practical and ethical challenges in implementing new
surveillance methods. Interviews captured nuanced expert
perspectives from a wide range of disciplinary backgrounds.
The primary limitation is that the purposive sample may not
reflect the breadth of views about D2C from all relevant
stakeholders. Because the majority of participants came from
North Carolina, and public health resources vary widely by
state, studies based in other locations may raise different issues.
Our interviews focused on the DOH model of D2C. Thus,
findings may not be generalizable to other models, such as the
use of patient registries generated by specific health care
systems.
Conclusions
This qualitative, descriptive study contributes valuable
information that will be useful for understanding future
applications of D2C and related surveillance methods.
Participants expressed a great deal of support for D2C, yet also
stressed the role of public trust and transparency in addressing
the practical and ethical concerns they identified. The next steps
for the ongoing expansion of D2C programs are
pre-implementation community engagement efforts to foster
public trust and transparency.
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